Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Warner

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Nervous and Mental Disease|October 29, 2010
The brain in a case of human cyclopiaO MARBURG, F J WARNER
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 8, 1998
Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptorsJ M Conlon, F J Warner, E Burcher
British Journal of Pharmacology|August 24, 1999
Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colonF J Warner, A Comis, R C Miller, et al.
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colonF J Warner, L Liu, D Z Lubowski, et al.
Peptides|October 24, 1998
Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinusF J Warner, E Burcher, R Carraway, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 24, 1999
Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of originL Liu, F J Warner, J M Conlon, et al.
Cellular and Molecular Life Sciences : CMLS|November 19, 2004
Angiotensin-converting enzyme-2: a molecular and cellular perspectiveF J Warner, A I Smith, N M Hooper, et al.
Biochemical Pharmacology|January 4, 2001
Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chiralityF J Warner, P Mack, A Comis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the ratE Velkoska, F J Warner, T J Cole, et al.
Biochimica Et Biophysica Acta|August 2, 2005
Membrane-associated zinc peptidase families: comparing ACE and ACE2J L Guy, D W Lambert, F J Warner, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Nervous and Mental Disease|October 29, 2010
The brain in a case of human cyclopiaO MARBURG, F J WARNER
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 8, 1998
Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptorsJ M Conlon, F J Warner, E Burcher
British Journal of Pharmacology|August 24, 1999
Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colonF J Warner, A Comis, R C Miller, et al.
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colonF J Warner, L Liu, D Z Lubowski, et al.
Peptides|October 24, 1998
Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinusF J Warner, E Burcher, R Carraway, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 24, 1999
Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of originL Liu, F J Warner, J M Conlon, et al.
Cellular and Molecular Life Sciences : CMLS|November 19, 2004
Angiotensin-converting enzyme-2: a molecular and cellular perspectiveF J Warner, A I Smith, N M Hooper, et al.
Biochemical Pharmacology|January 4, 2001
Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chiralityF J Warner, P Mack, A Comis, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the ratE Velkoska, F J Warner, T J Cole, et al.
Biochimica Et Biophysica Acta|August 2, 2005
Membrane-associated zinc peptidase families: comparing ACE and ACE2J L Guy, D W Lambert, F J Warner, et al.
Pageof 3